BAX Stock Overview
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
Baxter International Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$37.32 |
| 52 Week High | US$58.23 |
| 52 Week Low | US$37.20 |
| Beta | 0.61 |
| 1 Month Change | -10.14% |
| 3 Month Change | -17.21% |
| 1 Year Change | -31.27% |
| 3 Year Change | -52.81% |
| 5 Year Change | -51.72% |
| Change since IPO | 192.71% |
Recent News & Updates
There Are Reasons To Feel Uneasy About Baxter International's (NYSE:BAX) Returns On Capital
Sep 21
Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29
Aug 23Dividend Challengers Review: Baxter International
Aug 14Recent updates
There Are Reasons To Feel Uneasy About Baxter International's (NYSE:BAX) Returns On Capital
Sep 21Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29
Aug 23Dividend Challengers Review: Baxter International
Aug 14Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29
Jul 25Baxter International (NYSE:BAX) Has A Somewhat Strained Balance Sheet
Jul 14Baxter International: Hillrom Acquisition Could Be A Tailwind For FCF
Jun 12Returns On Capital At Baxter International (NYSE:BAX) Paint A Concerning Picture
Jun 07Baxter International's (NYSE:BAX) Dividend Will Be $0.29
May 19Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29
May 05Baxter International Inc.'s (NYSE:BAX) Intrinsic Value Is Potentially 26% Above Its Share Price
Apr 24Is Baxter International (NYSE:BAX) Using Too Much Debt?
Apr 03Baxter International's (NYSE:BAX) Dividend Will Be $0.29
Feb 18Investors Could Be Concerned With Baxter International's (NYSE:BAX) Returns On Capital
Feb 10Baxter International: Another YoY Earnings Decline Expected, Shares Tag Support
Feb 03Why Baxter Is One Of My #1 2023 Bets For Healthcare/Medtech
Jan 02An Intrinsic Calculation For Baxter International Inc. (NYSE:BAX) Suggests It's 32% Undervalued
Dec 30Baxter cut to hold at Deutsche Bank on inflation pressures
Dec 15Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29
Nov 18Baxter International: Despite Weakening On The Bottom Line, Shares Look Attractive
Oct 24Here's What's Concerning About Baxter International's (NYSE:BAX) Returns On Capital
Oct 05Baxter is said to evaluate sale of two of its kidney businesses
Sep 14Baxter reaches 52-week low; stock down 34% YTD
Aug 29These 4 Measures Indicate That Baxter International (NYSE:BAX) Is Using Debt Reasonably Well
Aug 19Baxter's Shares Are Starting To Look Cheap
Aug 11Are Investors Undervaluing Baxter International Inc. (NYSE:BAX) By 45%?
Aug 02Baxter Q2 2022 Earnings Preview
Jul 27Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29
Jul 17Baxter declares $0.29 dividend
Jul 12Baxter International (NYSE:BAX) Will Be Hoping To Turn Its Returns On Capital Around
Jul 06Baxter International (NYSE:BAX) Is Increasing Its Dividend To US$0.29
May 06Baxter: Some Real 'Buy' Appeal
May 03Are Investors Undervaluing Baxter International Inc. (NYSE:BAX) By 46%?
Apr 30Does Baxter International (NYSE:BAX) Have A Healthy Balance Sheet?
Apr 14Baxter International (NYSE:BAX) Could Be Struggling To Allocate Capital
Mar 30Baxter: A Potential Premium Upside Of 15%
Feb 22Shareholder Returns
| BAX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -4.2% | -4.0% | -3.8% |
| 1Y | -31.3% | 6.8% | 15.1% |
Return vs Industry: BAX underperformed the US Medical Equipment industry which returned 7.3% over the past year.
Return vs Market: BAX underperformed the US Market which returned 16.8% over the past year.
Price Volatility
| BAX volatility | |
|---|---|
| BAX Average Weekly Movement | 3.6% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in US Market | 14.2% |
| 10% least volatile stocks in US Market | 2.6% |
Stable Share Price: BAX is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: BAX's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1931 | 60,000 | Joe Almeida | https://www.baxter.com |
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories.
Baxter International Inc. Fundamentals Summary
| BAX fundamental statistics | |
|---|---|
| Market Cap | US$18.90b |
| Earnings (TTM) | -US$2.82b |
| Revenue (TTM) | US$15.18b |
1.2x
P/S Ratio-6.7x
P/E RatioIs BAX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BAX income statement (TTM) | |
|---|---|
| Revenue | US$15.18b |
| Cost of Revenue | US$9.29b |
| Gross Profit | US$5.89b |
| Other Expenses | US$8.70b |
| Earnings | -US$2.82b |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Nov 02, 2023
| Earnings per share (EPS) | -5.56 |
| Gross Margin | 38.78% |
| Net Profit Margin | -18.56% |
| Debt/Equity Ratio | 292.7% |
How did BAX perform over the long term?
See historical performance and comparison